Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
New data from the years 2012 to 2015 from the Danish National Fungemia Surveillance are reported, and epidemiological trends are investigated in a 12-year perspective (2004 to 2015). During 2012 to 2015, 1,900 of 1,939 (98%) fungal bloodstream isolates were included. The average incidence was 8.4/100,000 inhabitants, and this appears to represent a stabilizing trend after the increase to 10.1/100,000 in 2011. The incidence was higher in males than females (10.0 versus 6.8) and in patients above 50 years, and those changes were mainly driven by an increasing incidence among 80-to-89-year-old males (65.3/100,000 in 2014 to 2015). The proportion of Candida albicans isolates decreased from 2004 to 2015 (64.4% to 42.4%) in parallel with a doubling of the proportion of Candida glabrata isolates (16.5% to 34.6%,P< 0.0001).C. glabrata was more common among females (34.0% versus 30.4% in males). Following an increase in 2004 to 2011, the annual drug use stabilized during the last 2 to 3 years of that time period but remained higher than in other Nordic countries. This was particularly true for the fluconazole and itraconazole use in the primary health care sector, which exceeded the combined national levels of use of these compounds in each of the other Nordic countries. Fluconazole susceptibility decreased (68.5%, 65.2%, and 60.6% in 2004 to 2007, 2008 to 2011, and 2012 to 2015, respectively,P< 0.0001), and echinocandin resistance emerged in Candida(0%, 0.6%, and 1.7%, respectively,P< 0.001). Amphotericin B susceptibility remained high (98.7%). Among 16 (2.7%) echinocandin-resistant C. glabrata isolates (2012 to 2015), 13 harbored FKS mutations and 5 (31%) were multidrug resistant. The epidemiological changes and the increased incidence of intrinsic and acquired resistance emphasize the importance of continued surveillance and of strengthened focus on antifungal stewardship.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Self-citationAlexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 1×
“glabrata, and 31% were fluconazole cross resistant, as reported elsewhere (31, 59, 60).”
BackgroundGlobal trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649
Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal Infections
O'Donnell, K., Sutton, D. A., Rinaldi, M. G., Sarver, B. A. J., Balajee, S. A., Schroers, H.-J., Summerbell, R. C., Robert, V. A. R. G., Crous, P. W., Zhang, N., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00989-10 · Cited by 633
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362
Hope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12040 · Cited by 360
Self-citation
Research works printed but not linked: 1
- Lausch KR, Søgard M, Rosenvinge FS, Johansen HK, Boysen T, Røder BL, Mortensen KL, Nielsen L, Lemming LE, Olesen B, Leitz C, Kristensen L, Dzajic E, Østergård L, Schønheyder HC, Arendrup MC. 2017. Behind candidaemia: risk factors and outcome in a high-incidence nationwide setting, abstr OS0587. Abstr 27th ECCMID, 22 to 25 April 2017, Vienna, Austria.
Cited by
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Self-citationTackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467
“[141], non-azole oral agents are needed to treat such infections in an outpatient setting.”
BackgroundDrug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., Ilkit, M., Lass-Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 292
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Arendrup, M. C., Arikan-Akdagli, S., Jørgensen, K. M., Barac, A., Steinmann, J., Toscano, C., Arsenijevic, V. A., Sartor, A., Lass-Flörl, C., Hamprecht, A., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.08.001 · Cited by 123
Self-citationAntifungal Resistance: a Concerning Trend for the Present and Future
Hendrickson, J. A., Hu, C., Aitken, S. L., & Beyda, N. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0702-9 · Cited by 139
Quindós, G., Marcos‐Arias, C., San-Millán, R., Mateo, E., & Eraso, E. (2018) · International Microbiology · doi:10.1007/s10123-018-0014-1 · Cited by 131
Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.003 · Cited by 105
Pfaller, M. A., Huband, M. D., Flamm, R. K., Bien, P. A., & Castanheira, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-19 · Cited by 80
The effect of antifungal resistance development on the virulence of Candida species
Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 83
A One Health approach to overcoming fungal disease and antifungal resistance
Woods, M., McAlister, J. A., & Geddes‐McAlister, J. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1610 · Cited by 81
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland
Coste, A. T., Kritikos, A., Li, J., Khanna, N., Goldenberger, D., Garzoni, C., Zehnder, C., Boggian, K., Neofytos, D., Riat, A., et al. (2020) · Infection · doi:10.1007/s15010-020-01475-8 · Cited by 69
Khan, Z., Ahmad, S., Al-Sweih, N., Mokaddas, E., Al-Banwan, K., Alfouzan, W., Al-Obaid, I., Al-Obaid, K., Asadzadeh, M., Jeragh, A., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216250 · Cited by 65
Pfaller, M. A., Huband, M. D., Flamm, R. K., Bien, P. A., & Castanheira, M. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.04.012 · Cited by 70
Pfaller, M. A., Rhomberg, P. R., Wiederhold, N. P., Gibas, C. F. C., Sanders, C. J., Fan, H., Mele, J., Kovanda, L. L., & Castanheira, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-18 · Cited by 68
Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
Beardsley, J., Kim, H. Y., Dao, A., Kidd, S. E., Alastruey‐Izquierdo, A., Sorrell, T. C., Tacconelli, E., Chakrabarti, A., Harrison, T. S., Bongomin, F., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae041 · Cited by 61
Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 59
Arendrup, M. C., Chowdhary, A., Astvad, K. M. T., & Jørgensen, K. M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-18 · Cited by 53
Self-citationThe Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases
Schwartz, I. S., & Patterson, T. F. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0608-y · Cited by 57
Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis
Arendrup, M. C., Andersen, J. S., Holten, M., Krarup, K. B., Reiter, N., Schierbeck, J., & Helleberg, M. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz136 · Cited by 56
Self-citationMamali, V., Siopi, M., Charpantidis, S., Samonis, G., Tsakris, A., Vrioni, G., & on behalf of the Candi-Candi Network (2022) · Journal of Fungi · doi:10.3390/jof8020116 · Cited by 58
Chen, P.-Y., Chuang, Y.-C., Wu, U.-I., Sun, H.-Y., Wang, J.-T., Sheng, W.-H., Lo, H.-J., Wang, H.-Y., Chen, Y.-C., & Chang, S.-C. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190520 · Cited by 51
Rivero-Menéndez, O., Navarro-Rodríguez, P., Bernal‐Martínez, L., Martin-Cano, G., Lopez-Perez, L., Sánchez‐Romero, I., Pérez‐Ayala, A., Capilla, J., Zaragoza, Ó., & Alastruey‐Izquierdo, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01585 · Cited by 47
Mohsin, J., Weerakoon, S., Ahmed, S., Puts, Y., Al Balushi, Z., Meis, J. F., & Al-Hatmi, A. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9100638 · Cited by 43
Xu, Z., Green, B., Benoit, N., Schatz, M., Wheelan, S., & Cormack, B. (2020) · Molecular Microbiology · doi:10.1111/mmi.14488 · Cited by 48
Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W., & Li, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01401 · Cited by 46
Jørgensen, K. M., Astvad, K. M. T., Hare, R. K., & Arendrup, M. C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00073-19 · Cited by 42
Self-citationAstvad, K. M. T., Sanglard, D., Delarze, E., Hare, R. K., & Arendrup, M. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01624-18 · Cited by 43
Self-citationArastehfar, A., Daneshnia, F., Salehi, M., Yaşar, M., Hoşbul, T., Ilkit, M., Pan, W., Hagen, F., Arslan, N., Türk‐Dağı, H., et al. (2020) · Mycoses · doi:10.1111/myc.13104 · Cited by 42
Papp, C., Bohner, F., Kocsis, K., Varga, M., Szekeres, A., Bodai, L., Willis, J. R., Gabaldón, T., Tóth, R., Nosanchuk, J. D., et al. (2020) · mSphere · doi:10.1128/msphere.00821-20 · Cited by 42
Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort
Lausch, K. R., Dungu, K. H. S., Callesen, M. T., Schrøder, H. D., Rosthøj, S., Poulsen, A., Østergaard, L. J., Mortensen, K. L., Storgaard, M., Schønheyder, H. C., et al. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002207 · Cited by 47
Self-citationDíaz-García, J., Mesquida, A., Sánchez-Carrillo, C., Reigadas, E., Muñoz, P., Escribano, P., & Guinea, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01827-20 · Cited by 39
Rayens, E. A., Rabacal, W., Willems, H. M. E., Kirton, G. M., Barber, J. P., Mousa, J. J., Celia-Sanchez, B. N., Momany, M., & Norris, K. A. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac248 · Cited by 40
Ibrexafungerp: A narrative overview
Ayoubi, L. W. E., Allaw, F., Moussa, E., & Kanj, S. S. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100245 · Cited by 41
McTaggart, L. R., Cabrera, A. L., Cronin, K. I., & Kus, J. V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-20 · Cited by 39
Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician
Lamoth, F. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s375625 · Cited by 43
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey
Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab471 · Cited by 37
Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018)
Arastehfar, A. A., Yazdanpanah, S., Bakhtiari, M., Fang, W., Pan, W., Mahmoudi, S., Pakshir, K., Daneshnia, F., Boekhout, T., İlkit, M., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa059 · Cited by 41
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
Astvad, K. M. T., Arıkan-Akdağlı, S., & Arendrup, M. C. (2022) · Journal of Fungi · doi:10.3390/jof8020141 · Cited by 40
Self-citationGalia, L., Pezzani, M. D., Compri, M., Callegari, A., Rajendran, N. B., Carrara, E., Tacconelli, E., & the COMBACTE MAGNET EPI-Net Network (2022) · Journal of Fungi · doi:10.3390/jof8030249 · Cited by 39
Kord, M., Salehi, M., Khodavaisy, S., Hashemi, S. J., Ghazvini, R. D., Rezaei, S., Maleki, A., Elmimoghaddam, A., Alijani, N., Abdollahi, A., et al. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001189 · Cited by 36
Pfaller, M. A., Huband, M. D., Rhomberg, P. R., Bien, P. A., & Castanheira, M. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-22 · Cited by 37
Epigenetic Regulation of Antifungal Drug Resistance
Patra, S., Raney, M., Pareek, A., & Kaur, R. (2022) · Journal of Fungi · doi:10.3390/jof8080875 · Cited by 38
Rasheed, M., Battu, A., & Kaur, R. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792773 · Cited by 33
Risum, M., Astvad, K., Johansen, H. K., Schønheyder, H. C., Rosenvinge, F. S., Knudsen, J. D., Hare, R. K., Datcu, R., Røder, B. L., Antsupova, V. S., et al. (2021) · Journal of Fungi · doi:10.3390/jof7060491 · Cited by 36
Self-citationValotteau, C., Prystopiuk, V., Cormack, B. P., & Dufrêne, Y. F. (2019) · mSphere · doi:10.1128/msphere.00277-19 · Cited by 36
Posteraro, B., Carolis, E. D., Criscuolo, M., Ballanti, S., Angelis, G. D., Principe, M. I. D., Delia, M., Fracchiolla, N., Marchesi, F., Nadali, G., et al. (2020) · Mycoses · doi:10.1111/myc.13130 · Cited by 37
Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey
Klingspor, L., Ullberg, M., Rydberg, J., Kondori, N., Serrander, L., Swanberg, J., Nilsson, K., Bengtén, C. J., Johansson, M., Granlund, M., et al. (2018) · Mycoses · doi:10.1111/myc.12816 · Cited by 35
Changing epidemiology of non-albicans candidemia in Korea
Ko, J., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., Kim, S., et al. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.09.016 · Cited by 30
Kajihara, T., Yahara, K., Nagi, M., Kitamura, N., Hirabayashi, A., Hosaka, Y., Abe, M., Miyazaki, Y., & Sugai, M. (2022) · Medical Mycology · doi:10.1093/mmy/myac071 · Cited by 29
Cell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata
Xu, Z., Green, B., Benoit, N., Sobel, J. D., Schatz, M. C., Wheelan, S., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 29
Meyahnwi, D., Siraw, B. B., & Reingold, A. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07848-8 · Cited by 28
Odoj, K., Garlasco, J., Pezzani, M. D., Magnabosco, C., Ortiz, D., Manco, F., Galia, L., Foster, S. K., Arieti, F., & Tacconelli, E. (2024) · Journal of Fungi · doi:10.3390/jof10100685 · Cited by 34
Fraser, M., Borman, A. M., Thorn, R. M. S., & Lawrance, L. M. (2019) · Medical Mycology · doi:10.1093/mmy/myz053 · Cited by 32
Kim, J. H., Suh, J. W., & Kim, M. J. (2021) · Journal of Fungi · doi:10.3390/jof7040275 · Cited by 29
Evolution of fungemia in an Italian region
Prigitano, A., Cavanna, C., Passera, M., Gelmi, M. L., Sala, E., Ossi, C. M., Grancini, A., Calabrò, M., Bramati, S., Tejada, M., et al. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100906 · Cited by 24
Demin, K. A., Refeld, A. G., Bogdanova, A. A., Prazdnova, E. V., Popov, I. V., Kutsevalova, O. Y., Ermakov, A. M., Bren, A. B., Rudoy, D. V., Chistyakov, V. A., et al. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09776-6 · Cited by 25
Candida glabrata: A Tale of Stealth and Endurance
Askari, F., & Kaur, R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00477 · Cited by 24
Hernando-Ortiz, A., Mateo, E., Ortega-Riveros, M., De-la-Pinta, I., Quindós, G., & Eraso, E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-20 · Cited by 22
Pfaller, M. A., Carvalhaes, C. G., DeVries, S. D., Huband, M. D., & Castanheira, M. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115627 · Cited by 22
Moirangthem, R., Kumar, K., & Kaur, R. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02415-20 · Cited by 20
The yapsin family of aspartyl proteases regulate glucose homeostasis in Candida glabrata
Askari, F., Rasheed, M., & Kaur, R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101593 · Cited by 20
Bretagne, S., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Che, D., Dromer, F., & YEASTS, P. O. T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641965 · Cited by 19
Castanheira, M. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01907-17 · Cited by 19
Pfaller, M. A., Carvalhaes, C. G., Messer, S. A., Rhomberg, P. R., & Castanheira, M. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115473 · Cited by 18
Kooshki, P., Rezaei‐Matehkolaei, A., & Mahmoudabadi, A. Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.02.010 · Cited by 21
Bhakt, P., Raney, M., & Kaur, R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102485 · Cited by 17
The Utility of EQUAL Candida Score in Predicting Mortality in Patients with Candidemia
Zakhem, A. E., Eid, R. E., Istambouli, R., Tamim, H., & Kanj, S. S. (2022) · Journal of Fungi · doi:10.3390/jof8030238 · Cited by 20
SUMOylation in Human Pathogenic Fungi: Role in Physiology and Virulence
Sahu, M. S., Patra, S., Kumar, K., & Kaur, R. (2020) · Journal of Fungi · doi:10.3390/jof6010032 · Cited by 17
Szarvas, J., Rebelo, A. R., Bortolaia, V., Leekitcharoenphon, P., Hansen, D. S., Nielsen, H. L., Nørskov‐Lauritsen, N., Kemp, M., Røder, B. L., Møller, J. K., et al. (2021) · Journal of Fungi · doi:10.3390/jof7110962 · Cited by 16
Self-citationArastehfar, A. A., Marcet‐Houben, M., Daneshnia, F., Taj‐Aldeen, S. J., Batra, D. G., Lockhart, S. R., Shor, E., Gabaldón, T., & Perlin, D. S. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100133 · Cited by 18
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 17
Biofilm development of Candida boidinii and the effect of tyrosol on biofilm formation
Márton, R., Nagy, B., & Molnár, M. (2023) · Biotechnology Letters · doi:10.1007/s10529-023-03432-5 · Cited by 14
Systemic antifungal drug use in Belgium—One of the biggest antifungal consumers in Europe
Goemaere, B., Lagrou, K., Spriet, I., Hendrickx, M., Vandael, E., Becker, P., & Catry, B. (2019) · Mycoses · doi:10.1111/myc.12912 · Cited by 14
Chen, M., Hu, D., Li, T., Zheng, D., Liao, W., Xia, X., & Cao, C. (2023) · Mycopathologia · doi:10.1007/s11046-023-00757-7 · Cited by 14
Zeng, B., Zeng, B., Hung, C., Chen, T., Wu, Y., Tu, Y., Lin, P., Su, K., Stubbs, B., Sun, C., et al. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1922078 · Cited by 15
Bordallo-Cardona, M. Á., Marcos-Zambrano, L. J., Sánchez‐Carrillo, C., Bouza, E., Muñóz, P., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00162-18 · Cited by 14
Okamoto, M., Nakano, K., Takahashi-Nakaguchi, A., Sasamoto, K., Yamaguchi, M., Teixeira, M. C., & Chibana, H. (2023) · Journal of Fungi · doi:10.3390/jof9020240 · Cited by 11
Bordallo-Cardona, M. Á., Sánchez‐Carrillo, C., Bouza, E., Muñóz, P., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02004-18 · Cited by 12
Tala-Ighil, T., Garcia‐Hermoso, D., Dalle, F., Cassaing, S., Guitard, J., Sitbon, K., Obadia, T., Lortholary, O., Letscher‐Bru, V., Ledoux, M., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciae594 · Cited by 10
Lausch, K. R., Søgaard, M., Rosenvinge, F. S., Johansen, H. K., Boysen, T., Røder, B. L., Mortensen, K. L., Nielsen, L. B., Lemming, L. E., Olesen, B. R. S., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s176384 · Cited by 11
Self-citationShwab, E. K., Juvvadi, P. R., Waitt, G. M., Shaheen, S. K., Allen, J., Soderblom, E. J., Bobay, B. G., Asfaw, Y. G., Moseley, M. A., & Steinbach, W. J. (2020) · mBio · doi:10.1128/mbio.02880-20 · Cited by 11
Deng, R., Meng, X., Li, R., Wang, A., & Song, Y. (2023) · Medicine · doi:10.1097/md.0000000000033798 · Cited by 10
Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county
Klingspor, H. T., & Hällgren, A. (2024) · Mycoses · doi:10.1111/myc.13758 · Cited by 9
Helweg‐Larsen, J., Steensen, M., Pedersen, F. M., Jensen, P. B., Perch, M., Møller, K., Olesen, B. R., Søderlund, M., & Arendrup, M. C. (2021) · Journal of Fungi · doi:10.3390/jof7121044 · Cited by 9
Self-citationKaur, H., Krishnamoorthi, S., Dhaliwal, N., Biswal, M., Singh, S., Muthu, V., Rudramurthy, S. M., Agarwal, R., Ghoshal, S., Singh, S., et al. (2022) · Mycoses · doi:10.1111/myc.13514 · Cited by 9
Emerging trends of invasive yeast infections and azole resistance in Beijing intensive care units
Yu, J., Yang, W., Fan, X., Cui, E., Min, R., Yuan, H., Hu, Y., Wang, H., Zhang, G., Zhao, Y. Y., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.04.020 · Cited by 8
Fatal chronic meningitis caused by Candida dubliniensis after liver transplantation
Gheshlaghi, M., & Helweg‐Larsen, J. (2019) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2019.12.009 · Cited by 9
Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
Suh, J. W., Kim, S. B., Yoon, Y. K., Sohn, J. W., Kim, M. J., & Kim, J. H. (2020) · Mycopathologia · doi:10.1007/s11046-020-00471-8 · Cited by 8
Battu, A., Purushotham, R., Dey, P., Vamshi, S. S., & Kaur, R. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009355 · Cited by 9
Insights into the role of sphingolipids in antifungal drug resistance
Kalra, S., Tanwar, S., & Bari, V. K. (2023) · Fungal Biology Reviews · doi:10.1016/j.fbr.2023.100342 · Cited by 8
Li, K., Yang, X., Long, L., & Zhi, L. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s477815 · Cited by 8
Nascimento, T., Inácio, J., Guerreiro, D., Diaz, P., Patrício, P., Proença, L., Toscano, C., & Barroso, H. (2024) · Infection Prevention in Practice · doi:10.1016/j.infpip.2024.100403 · Cited by 9
Sahu, M. S., Purushotham, R., & Kaur, R. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011281 · Cited by 7
Epidemiology of Candidemia in Mashhad, Northeast Iran: A Prospective Multicenter Study (2019–2021)
Dolatabadi, S., Najafzadeh, M. J., Raeisabadi, A., Zarrinfar, H., Jalali, M., Spruijtenburg, B., Meijer, E. F. J., Meis, J. F. G. M., Lass‐Flörl, C., & de Groot, T. (2024) · Journal of Fungi · doi:10.3390/jof10070481 · Cited by 9
Gil-Alonso, S., Quindós, G., Eraso, E., & Jauregizar, N. (2019) · PubMed Central · Cited by 7
Jain, K., Shukla, N., Kaur, A., Kalita, B., Srivastava, S., Yadav, S., Rani, P., Kagra, P., Singh, A. K., Chaudhary, K., et al. (2026) · mBio · doi:10.1128/mbio.00235-26 · Cited by 6
Metadata
- Authors
- Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., Gertsen, J. B., Dzajic, E., Pedersen, M., Østergård, C., Olesen, B., Søndergaard, T. S., & Arendrup, M. C.
- Affiliations
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Slagelse Hospital (DK)
- Odense University Hospital (DK)
- Hvidovre Hospital (DK)
- Aarhus University Hospital (DK)
- Aalborg University Hospital (DK)
- Hospital South West Jutland (DK)
- Department of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark
- Sygehus Sønderjylland (DK)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-04
- Volume
- 56
- Issue
- 4
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5869841
- OpenAlex
- W2773217499
- Cited by
- 125
- References
- 62
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 12 · 2023: 12 · 2022: 19 · 2021: 20 · 2020: 18 · 2019: 16 · 2018: 14
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- VBN Forskningsportal (Aalborg Universitet) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
- Funders
- Pfizer
- Gilead Sciences
- Cidara Therapeutics
- Amplyx
- Novo Nordisk
- Astellas Pharma
- Novo Nordisk Fonden (NNF12OC1015920)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- fungemia, antifungal resistance, Candida glabrata, Candida albicans, fluconazole resistance, echinocandin resistance, amphotericin B susceptibility, epidemiological trends, incidence, Denmark, Nordic countries, surveillance data, itraconazole
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Amphotericin B, Antifungal Agents, Candida, Candida albicans, Denmark, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Sex Factors, Fluconazole, Incidence, Fungemia, Itraconazole, Drug Resistance, Multiple, Fungal, Candida glabrata, Echinocandins, Epidemiological Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.